Debra K. Liebert - 20 Oct 2022 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
MIST
Transactions as of
20 Oct 2022
Net transactions value
+$73,940
Form type
4
Filing time
21 Oct 2022, 19:02:01 UTC
Previous filing
15 Sep 2022
Next filing
09 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIST Common Shares Purchase $52,900 +10,000 $5.29 10,000 20 Oct 2022 By: The Rodriguez and Liebert Revocable Trust F1
transaction MIST Common Shares Purchase $21,040 +4,000 $5.26 4,000 21 Oct 2022 By: Trust F2
holding MIST Common Shares 127 20 Oct 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.24 to $5.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 These shares are held in a trust for the benefit of several including the Reporting Person's spouse. The Reporting Person's spouse is a co-executor of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.